PMC:7600245 / 81282-81586 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T361","span":{"begin":38,"end":44},"obj":"Body_part"},{"id":"T362","span":{"begin":58,"end":64},"obj":"Body_part"},{"id":"T363","span":{"begin":106,"end":121},"obj":"Body_part"},{"id":"T364","span":{"begin":199,"end":202},"obj":"Body_part"},{"id":"T365","span":{"begin":215,"end":219},"obj":"Body_part"},{"id":"T366","span":{"begin":275,"end":297},"obj":"Body_part"},{"id":"T367","span":{"begin":292,"end":297},"obj":"Body_part"}],"attributes":[{"id":"A361","pred":"fma_id","subj":"T361","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A362","pred":"fma_id","subj":"T362","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A363","pred":"fma_id","subj":"T363","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A364","pred":"fma_id","subj":"T364","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A365","pred":"fma_id","subj":"T365","obj":"http://purl.org/sig/ont/fma/fma74402"},{"id":"A366","pred":"fma_id","subj":"T366","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A367","pred":"fma_id","subj":"T367","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"These include the use of convalescent plasma (hyperimmune plasma) from fully recovered individuals [302], immunoglobulins, INFs (such as INF β-1a, INF β-1b, pegylated INF γ-1a and others) [303,304], RNA virus-based gene vector (such as DeltaRex-G) (NCT04378244; n = 18), and mesenchymal stem cells [305]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T848","span":{"begin":38,"end":44},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T849","span":{"begin":58,"end":64},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T850","span":{"begin":144,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T851","span":{"begin":154,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T852","span":{"begin":174,"end":175},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T853","span":{"begin":203,"end":208},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T854","span":{"begin":215,"end":219},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T855","span":{"begin":262,"end":268},"obj":"http://purl.obolibrary.org/obo/CLO_0007919"},{"id":"T856","span":{"begin":262,"end":268},"obj":"http://purl.obolibrary.org/obo/CLO_0007920"},{"id":"T857","span":{"begin":275,"end":297},"obj":"http://purl.obolibrary.org/obo/CL_0000134"}],"text":"These include the use of convalescent plasma (hyperimmune plasma) from fully recovered individuals [302], immunoglobulins, INFs (such as INF β-1a, INF β-1b, pegylated INF γ-1a and others) [303,304], RNA virus-based gene vector (such as DeltaRex-G) (NCT04378244; n = 18), and mesenchymal stem cells [305]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T639","span":{"begin":0,"end":304},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These include the use of convalescent plasma (hyperimmune plasma) from fully recovered individuals [302], immunoglobulins, INFs (such as INF β-1a, INF β-1b, pegylated INF γ-1a and others) [303,304], RNA virus-based gene vector (such as DeltaRex-G) (NCT04378244; n = 18), and mesenchymal stem cells [305]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2542","span":{"begin":141,"end":155},"obj":"Gene"}],"attributes":[{"id":"A2542","pred":"tao:has_database_id","subj":"2542","obj":"Gene:5265"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These include the use of convalescent plasma (hyperimmune plasma) from fully recovered individuals [302], immunoglobulins, INFs (such as INF β-1a, INF β-1b, pegylated INF γ-1a and others) [303,304], RNA virus-based gene vector (such as DeltaRex-G) (NCT04378244; n = 18), and mesenchymal stem cells [305]."}